Please login to the form below
Deal Watch table for August 2013
Table listing all the major pharma mergers, acquisitions and collaborations in the past month
This table lists all the major pharma collaborations, acquisitions and mergers agreed during August 2013.
For an indepth analysis of these deals, read 'Pharma deals during August 2013'
|
Licensor acquired / licensee acquirer |
Deal type |
Product / technology |
Headline ($m) |
| Onyx Pharmaceuticals / Amgen | Acquisition | Cancer drugs including Kyprolis, Nexavar and Stivarga | 10,400 |
| Hi-Tech Pharmacal / Akorn |
Acquisition | Develops, manufactures and markets generic and branded prescription and OTC products | 640 |
| Compugen / Bayer |
Collaboration and licence agreement | Research, development, and commercialisation of antibody-based therapeutics for cancer immunotherapy against two novel checkpoint regulators | 540 |
| Amplimmune / AstraZeneca |
Acquisition | AMP-514, a preclinical PD-1 monoclonal antibody. Other pipeline assets include several preclinical molecules targeting the B7 pathways | 500 |
| Systagenix / Kinetic Concepts |
Merger and acquisition | Advanced wound care products | 485 |
| OptiMedica / Abbott |
Acquisition | Ophthalmic device company | 400 |
| Thornton & Ross / Stada Arzneimittel |
Acquisition | OTC manufacturer | 345 |
| Endosense / St Jude Medical |
Acquisition | Catheter ablation | 331 |
| Medafor / C. R. Bard |
Acquisition | Arista® MPH Hemostat | 280 |
| ProFibrix / The Medicines Company |
Acquisition | Fibrocaps, dry powder haemostat | 240 |
| Boca Pharmacal / Qualitest |
Acquisition | Speciality generics | 225 |
| ImmunoGen Inc / Lilly |
Licence | Maytansinoid-based Targeted Antibody Payload (TAP) technology | 200.5 |
| Cardiocom / Medtronic |
Acquisition | Remote monitoring devices and telehealth technologies | 200 |
| Crealta Pharmaceuticals / GTCR, Ed Fiorentino | JV | Speciality pharmaceuticals | 200 |
| Merck & Co / Avanir Pharmaceuticals |
Co-promotion | Januvia, Janumet and Jamumet XR in nursing homes | 180 |
| GardenHills / Veropharm |
Acquisition | Generic drug manufacture | 151 |
| Acton Pharmaceuticals / Meda | Acquisition | Respiratory medicines including the inhaled corticosteroid Aerospan™ (flunisolide) for the treatment of asthma | 135 |
| Theragenics / Jupiter |
Acquisition | Surgical device manufacturer | 68 |
| Immco Diagnostics / Trinity Biotech |
Acquisition | Development, manufacture and sale of autoimmune test kits | 33 |
| Pernix Therapeutics / Breckenridge Pharma | Acquisition | 11 Abbreviated New Drug Applications (ANDAs), certain ANDAs in various stages of development, 7 marketed products | 30 |
Subscribe to our email news alerts
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Bristol Myers Squibb presents positive results for idiopathic pulmonary fibrosis drug
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Porterhouse Medical Group
The Porterhouse Medical Group provides powerful, insight-driven, healthcare communication services to the pharmaceutical industry across the globe, with a focus...
